InflaRx (IFRX) Intangibles (2016 - 2026)

InflaRx's (IFRX) quarterly Intangibles came in at $53382.5 in Q1 2026, down 6.26% year-on-year from $56944.8 in Q1 2025, and up 8.53% quarter-over-quarter from $49186.7 in Q4 2025.

InflaRx (IFRX) Intangibles (2016 - 2026) Analysis & Trends

InflaRx has disclosed Intangibles across 11 years of filings, most recently posting $53382.5 for Q1 2026.

  • Intangibles for Q1 2026 came in at $53382.5, down 6.26% year-over-year; the trailing twelve-month figure through Mar 2026 was $53382.5 (down 6.26% YoY), and the FY2025 annual result was $49186.7, down 9.36% from the prior year.
  • Intangibles came in at $53382.5 for Q1 2026 at InflaRx, up from $49186.7 in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $235486.7 in Q1 2022 to a low of $48136.1 in Q3 2024.
  • The 5-year median for Intangibles is $56944.8 (2025), against an average of $93394.4.
  • Across the five-year window, Intangibles tumbled 55.79% in 2023 and climbed 17.36% in 2025, its largest moves.
  • InflaRx's Intangibles stood at $141717.5 in 2022, then tumbled by 47.75% to $74044.0 in 2023, then dropped by 26.71% to $54264.3 in 2024, then declined by 9.36% to $49186.7 in 2025, then climbed by 8.53% to $53382.5 in 2026.
  • The last three Intangibles figures came in at $53382.5 (Q1 2026), $49186.7 (Q4 2025), and $53988.1 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 4.41 Mn
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 30.30 Mn
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 418.50 Mn
9 Abivax 94.26 Bn 94.26 Bn - 7.73 Mn
10 InflaRx 764.68 Mn 764.68 Mn 10,877.40 53,382.49

Historic Data

Download Data
DateValue
Mar 31, 2026 53,382.49
Dec 31, 2025 49,186.66
Sep 30, 2025 53,988.13
Jun 30, 2025 56,717.97
Mar 31, 2025 56,944.82
Dec 31, 2024 54,264.34
Sep 30, 2024 48,136.06
Jun 30, 2024 48,326.41
Mar 31, 2024 56,648.33
Dec 31, 2023 74,044.03
Sep 30, 2023 72,646.00
Jun 30, 2023 98,862.36
Mar 31, 2023 123,270.09
Dec 31, 2022 141,717.46
Sep 30, 2022 164,311.41
Jun 30, 2022 199,772.22
Mar 31, 2022 235,486.66
Dec 31, 2021 269,080.27
Sep 30, 2021 309,729.20
Jun 30, 2021 351,609.93